Patients who have had a Reconstruction of the Anterior Cruciate Ligament. We want to investigate wheater Ropivacain can be used as a postoperative analgetic drug, when applied ultrasound-guided as a nerve block perineuraly around the saphenus nerve in the adductor canal. This could be an alternative method for postoperative analgesia with less side-effects than iv-administrated opioid/neuroaxial blockade. MedDRA version: 12.1 Level: LLT Classification code 10036236 Term: Postoperative pain rel
Conditions
Interventions
Trade Name: Naropin 7,5 mg/mL
Product Name: Ropivacain
Product Code: 17973
Pharmaceutical Form: Injection*
INN or Proposed INN: ROPIVACAINE HYDROCHLORIDE
CAS Number: 0
Concentration unit: mg/ml milli
Sponsors
Professor Jørgen B. Dahl
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 18-70 years of age Surgery in general anesthesia (day-case surgery) ASA-group I-II BMI 19-35 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Patients who do not speak danish Allergic reaktions toward drugs used in the trial Abuse of alcohol/other drugs Patients who can not be mobilised Patients who can't cooperate (e.g dementia) Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Pain/VAS-score, patient standing, 2 hours postoperative;Secondary Objective: Pain/VAS-score at rest at different times Pain/VAS-score standing/when mobilised, after 5 meters walk at different times Postoperative pioid-consumption Postoperative nausea/vomiting Postoperative sedation ;Primary end point(s): VAS-score 2 hours post surgery, when standing | — |
Countries
Denmark
Outcome results
None listed